ID

45150

Description

Principal Investigator: Sudha K. Iyengar, PhD, Case Western Reserve University, Cleveland, OH, USA MeSH: Diabetes Mellitus,Kidney Diseases,Diabetic Nephropathies https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000333 The Family Investigation of Nephropathy and Diabetes (FIND) is a multicenter study designed to identify genetic determinants of diabetic kidney disease. Study subjects were recruited from eleven centers and in many ethnic groups throughout the United States. A genome-wide association study (GWAS) was conducted with the Affymetrix 6.0 chip. Subjects (index cases) with diabetes and kidney disease were initially recruited, and their parents and siblings were invited to participate. Genetic material from these participants was used to genotype markers throughout the genome. For association-based testing, a case-control design was implemented with study subjects selected primarily from the index cases of the families. Unrelated controls were selected from families where a case was not already selected. Several study sites also contributed non-FIND subjects, both cases and controls (consent forms for the release of FIND and non-FIND subjects/samples are included in this dbGaP release). Cases were selected if they met study criteria for diabetic nephropathy or met inclusion criteria based on elevated serum creatinine levels and abnormal urine protein excretion. Similarly, controls were long-term diabetics with otherwise normal kidney function. See inclusion/exclusion criteria section for a detailed description for the FIND study as a whole and this GWAS. The goal of the FIND study is to identify genes that influence susceptibility to diabetic kidney disease, leading to a better understanding of how kidney disease develops. In the long run, this may lead to improved treatment and prevention of diabetic kidney disease.

Lien

dbGaP study = phs000333

Mots-clés

  1. 10/09/2022 10/09/2022 - Simon Heim
  2. 12/10/2022 12/10/2022 - Adrian Schulz
Détendeur de droits

Sudha K. Iyengar, PhD, Case Western Reserve University, Cleveland, OH, USA

Téléchargé le

12 octobre 2022

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

dbGaP phs000333 Family Investigation of Nephropathy and Diabetes (FIND) Study

Subject ID, consent group, and affection status of participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.

  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, consent group, and affection status of participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.
    3. Subject ID, family ID, father and mother IDs, and sex of participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.
    4. Sample ID and subject ID of participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.
    5. Sociodemographic data including sex, race, age, and subject ID, medical history of participant's laboratory tests including creatinine ratio, glomerular filtration rate, serum creatinine, urine albumin excretion, urine creatinine excretion, urine protein excretion, laboratory tests of albumin-to-creatinine ratio, glomerular filtration rate, hemoglobin A1c, protein-to-creatinine ratio, serum creatinine, urine albumin excretion, urine creatinine excretion, urine protein excretion, health status including diabetes, high blood pressure, kidney failure, leg amputation, retinopathy, anthropometry, and ACE inhibitors or insulin administration of participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.
    6. Sample ID, tumor status, body site where from sample was collected, histological type of samples where from DNA was extracted obtained from participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.
pht002311
Description

pht002311

Subject ID
Description

SubjectId

Type de données

string

Alias
UMLS CUI [1,1]
C2348585
Consent group released to dbGaP
Description

Consent

Type de données

text

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1257890
Case/Control status of the subject [Case, Control, ControlLooseCriteria, CaseLooseCriteria, NA]
Description

AffectionStatus

Type de données

text

Alias
UMLS CUI [1,1]
C3274646

Similar models

Subject ID, consent group, and affection status of participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.

  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, consent group, and affection status of participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.
    3. Subject ID, family ID, father and mother IDs, and sex of participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.
    4. Sample ID and subject ID of participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.
    5. Sociodemographic data including sex, race, age, and subject ID, medical history of participant's laboratory tests including creatinine ratio, glomerular filtration rate, serum creatinine, urine albumin excretion, urine creatinine excretion, urine protein excretion, laboratory tests of albumin-to-creatinine ratio, glomerular filtration rate, hemoglobin A1c, protein-to-creatinine ratio, serum creatinine, urine albumin excretion, urine creatinine excretion, urine protein excretion, health status including diabetes, high blood pressure, kidney failure, leg amputation, retinopathy, anthropometry, and ACE inhibitors or insulin administration of participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.
    6. Sample ID, tumor status, body site where from sample was collected, histological type of samples where from DNA was extracted obtained from participants involved in the Family Investigation of Nephropathy and Diabetes [FIND] project and affected or not affected with diabetic kidney disease.
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
pht002311
SubjectId
Item
Subject ID
string
C2348585 (UMLS CUI [1,1])
Item
Consent group released to dbGaP
text
C0021430 (UMLS CUI [1,1])
C1257890 (UMLS CUI [1,2])
Code List
Consent group released to dbGaP
CL Item
Subjects did not participate in the study, did not complete a consent document and are included only for the pedigree structure and/or genotype controls, such as HapMap subjects (0)
CL Item
Diabetes, Kidney Disease, Retinopathy and/or Related Diseases (DNAR) (1)
Item
Case/Control status of the subject [Case, Control, ControlLooseCriteria, CaseLooseCriteria, NA]
text
C3274646 (UMLS CUI [1,1])
Code List
Case/Control status of the subject [Case, Control, ControlLooseCriteria, CaseLooseCriteria, NA]
CL Item
Case (Case)
CL Item
Other (CaseLooseCriteria)
CL Item
Control (Control)
CL Item
Other (ControlLooseCriteria)
CL Item
Not applicable (NA)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial